6-Chloropyrimidine-4-carbaldehyde

Catalog No. :
ACGHBF763
CAS No. :
933702-16-0
Molecular Formula :
C5H3ClN2O
Molecular Weight :
142.54

IUPAC Name:6-chloropyrimidine-4-carbaldehyde

6-Chloropyrimidine-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$378.00Login to see priceIn stockInquiry
250mg95%$629.00Login to see priceIn stockInquiry
500mg95%$881.00Login to see priceIn stockInquiry
1g95%$1258.00Login to see priceIn stockInquiry
5g95%$3773.00Login to see priceInquiryInquiry
10g95%$6288.00Login to see priceInquiryInquiry
25g95%$12575.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloropyrimidine-4-carbaldehyde
IUPAC Name6-chloropyrimidine-4-carbaldehyde
MDL No.MFCD10697049
Molecular FormulaC5H3ClN2O
Molecular Weight142.54
SMILESO=CC1=NC=NC(Cl)=C1
InChI KeyVFORWTKKMGPWFM-UHFFFAOYSA-N
Synonym6-chloropyriMidine-4-carbaldehyde;4-Pyrimidinecarboxaldehyde, 6-chloro-;6-Chloro-4-pyrimidinecarbaldehyde;6-chloro-4-Pyrimidinecarboxaldehyde;6-Chloropyrimidine-4-carboxaldehyde;6-chloropyrimidine-4-carbaldehyde - [C87958]
CAS No.933702-16-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H317-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGHBF763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHBF763 route product structure diagram
    ACGHBF763933702-16-0 In Stock
Inquiry

2. ACGHBF763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLQMF278 route compound structure diagram
    ACLQMF2781025351-41-0 In Stock
  2. Then
  3. ACGHBF763 route product structure diagram
    ACGHBF763933702-16-0 In Stock
Inquiry

Comments (0)